全文获取类型
收费全文 | 4614篇 |
免费 | 316篇 |
国内免费 | 3篇 |
专业分类
耳鼻咽喉 | 168篇 |
儿科学 | 75篇 |
妇产科学 | 74篇 |
基础医学 | 669篇 |
口腔科学 | 240篇 |
临床医学 | 423篇 |
内科学 | 852篇 |
皮肤病学 | 46篇 |
神经病学 | 466篇 |
特种医学 | 188篇 |
外科学 | 607篇 |
综合类 | 21篇 |
一般理论 | 3篇 |
预防医学 | 411篇 |
眼科学 | 109篇 |
药学 | 248篇 |
中国医学 | 7篇 |
肿瘤学 | 326篇 |
出版年
2023年 | 43篇 |
2022年 | 31篇 |
2021年 | 55篇 |
2020年 | 70篇 |
2019年 | 107篇 |
2018年 | 98篇 |
2017年 | 87篇 |
2016年 | 72篇 |
2015年 | 76篇 |
2014年 | 93篇 |
2013年 | 158篇 |
2012年 | 220篇 |
2011年 | 212篇 |
2010年 | 123篇 |
2009年 | 118篇 |
2008年 | 215篇 |
2007年 | 190篇 |
2006年 | 181篇 |
2005年 | 196篇 |
2004年 | 177篇 |
2003年 | 144篇 |
2002年 | 141篇 |
2001年 | 174篇 |
2000年 | 147篇 |
1999年 | 110篇 |
1998年 | 51篇 |
1997年 | 35篇 |
1996年 | 49篇 |
1995年 | 41篇 |
1994年 | 35篇 |
1993年 | 34篇 |
1992年 | 87篇 |
1991年 | 100篇 |
1990年 | 117篇 |
1989年 | 103篇 |
1988年 | 68篇 |
1987年 | 86篇 |
1986年 | 77篇 |
1985年 | 66篇 |
1984年 | 65篇 |
1983年 | 46篇 |
1982年 | 44篇 |
1980年 | 33篇 |
1979年 | 61篇 |
1978年 | 37篇 |
1977年 | 31篇 |
1975年 | 35篇 |
1974年 | 38篇 |
1973年 | 31篇 |
1970年 | 35篇 |
排序方式: 共有4933条查询结果,搜索用时 15 毫秒
991.
Juul K Andersen J Basile Cvitanich V Meldgaard Lund A 《Acta paediatrica (Oslo, Norway : 1992)》2006,95(10):1322-3; discussion 1325-6
992.
993.
Pedersen CB Bischoff C Christensen E Simonsen H Lund AM Young SP Koeberl DD Millington DS Roe CR Roe DS Wanders RJ Ruiter JP Keppen LD Stein Q Knudsen I Gregersen N Andresen BS 《Pediatric research》2006,60(3):315-320
The isobutyryl-CoA dehydrogenase (IBD) enzyme is involved in the degradation of valine. IBD deficiency was first reported in 1998 and subsequent genetic investigations identified acyl-CoA dehydrogenase (ACAD) 8, now IBD, as the gene responsible for IBD deficiency. Only three individuals homozygous or compound heterozygous for variations in the IBD gene have been reported. We present IBD deficiency in an additional four newborns with elevated C(4)-carnitine identified by tandem mass spectrometry (MS/MS) screening in Denmark and the United States. Three showed urinary excretions of isobutyryl-glycine, and in vitro probe analysis of fibroblasts from two newborns indicated enzymatic IBD defect. Molecular genetic analysis revealed seven new rare variations in the IBD gene (c.348C>A, c.400G>T, c.409G>A, c.455T>C, c.958G>A, c.1000C>T and c.1154G>A). Furthermore, sequence analysis of the short-chain acyl-CoA dehydrogenase (SCAD) gene revealed heterozygosity for the prevalent c.625G>A susceptibility variation in all newborns and in the first reported IBD patient. Functional studies in isolated mitochondria demonstrated that the IBD variations present in the Danish newborn (c.409G>A and c.958G>A) together with a previously published IBD variation (c.905G>A) disturbed protein folding and reduced the levels of correctly folded IBD tetramers. Accordingly, low/no IBD residual enzyme activity was detectable when the variant IBD proteins were overexpressed in Chang cells. 相似文献
994.
From many years, treatment of temporomandibular pain and other related disorders has been based on the “vicious cycle theory”, which postulates that chronic pain enhances muscular activity, which in return maintains the pain. Clinical and experimental evidence do not support this model and rather suggest that pain reduces maximum voluntary contraction by reducing agonist muscle activity, while increasing antagonist muscle activity. The pain-adaptation model, which takes these findings into account, suggests that therapeutic approaches should be revised accordingly. 相似文献
995.
996.
997.
Frederiksen BL Cayé-Thomasen P Lund SP Wagner N Asal K Olsen NV Thomsen J 《Hearing research》2007,223(1-2):129-137
Noise-induced hearing loss may result from excessive release of glutamate, nitrogen oxide and reactive oxygen species. The effects of these factors on the inner ear may potentially be prevented or reduced by erythropoietin (EPO), as indicated by previously demonstrated neuro-protective effects of EPO upon damage to the central nervous system and the retina. This paper reports three separate trials, conducted to investigate the hypothesis that noise-induced hearing loss is prevented or reduced by erythropoietin. The trials employed three different modes of drug application, different administration time windows and different rodent species. In trial 1, guinea pigs were exposed to 110dB SPL, 4-20kHz wide band noise (WBN) for 8h. EPO was administered to the round window membrane 24h after noise exposure, either sustained by pump for a week or by single dose middle ear instillation. In trial 2, rats were exposed to 105dB SPL, 4-20kHz WBN for 8h. EPO was administered by single dose middle ear instillation 1 or 14h after noise exposure. In trial 3, rats were exposed to 105dB SPL, 4-20kHz WBN for 8 or 3x8h. EPO was injected intraperitoneally 1h before noise exposure. Oto-acoustic emissions and auditory brainstem responses (at 16kHz) were recorded before and after noise exposure in all trials. The noise exposure induced a hearing loss in all animals. In trial 1, no recovery and no improvement of hearing occurred in any treatment group. In trial 2 and 3, a partial hearing recovery was seen. However, the hearing loss of the EPO treated animals was significantly worse than controls in trial 2. In trial 3, the hearing of the EPO treated animals exposed for 3x8h was significantly worse than controls. Thus, surprisingly, the results from 2 of the 3 present trials indicate that erythropoietin may in fact augment noise-induced hearing loss. This is contradictory to the beneficial effect of EPO reported by the vast majority of studies on stressed neural tissues. EPO administration may alter the blood flow dynamics of the cochlear vascular bed during or after noise exposure, by a potential induction of vasoconstriction. This may be the cause of the surprising findings. 相似文献
998.
A 28-year-old man with a history of total colonic Hirschsprung’s disease treated with a Duhamel–Martin procedure in infancy,
presented with signs and symptoms of acute colonic diverticulitis. Flexible sigmoidoscopy demonstrated a 20 cm jejunocolonic
anastomosis, consistent with his previous operation in childhood, with a large diverticulum at the proximal end of the anastomosis
containing fecal concretions. The patient returned one month later after a course of antibiotics for definitive resection
of the diverticulum. Intra-operative colonoscopy localized three large diverticula and resection of the involved segment was
performed. The case is presented as an adult complication of total colonic Hirschsprung’s disease treated with childhood resection
and reconstruction. 相似文献
999.
1000.
McGill TJ Prusky GT Douglas RM Yasumura D Matthes MT Nune G Donohue-Rolfe K Yang H Niculescu D Hauswirth WW Girman SV Lund RD Duncan JL LaVail MM 《Investigative ophthalmology & visual science》2007,48(12):5756-5766
PURPOSE: CNTF is a neuroprotective agent for retinal degenerations that can cause reduced electroretinogram (ERG) amplitudes. The goal of the present study was to determine the effects of intraocular delivery of CNTF on normal rat visual function. METHODS: Full-field scotopic and photopic ERG amplitudes and spatial frequency thresholds of the optokinetic response (OKR) of adult Long-Evans rats were measured before and after intravitreous injection of CNTF or subretinal delivery of adenoassociated virus-vectored CNTF (AAV-CNTF) into one eye. Visual acuity was also measured by using the Visual Water Task in AAV-CNTF-injected animals. Multiunit luminance thresholds were recorded in the superior colliculus after CNTF injection, and the eyes were examined histologically. RESULTS: In eyes injected with a high dose of CNTF, ERG amplitudes and OKR thresholds measured through CNTF-injected eyes were decreased by 45% to 70% within 6 days after injection. ERG amplitudes had begun to recover by 21 days, whereas OKR thresholds only began to recover after 56 days. Neither OKR thresholds nor ERG amplitudes fully recovered until 90 to 100 days. When measured in the superior colliculus at 2 weeks after CNTF injection, luminance thresholds were elevated by 0.35 log units. In AAV-CNTF-injected eyes, OKR thresholds, and visual acuity were reduced by approximately 50% for at least 6 months, and scotopic and photopic ERG b-waves were reduced by 30% to 50%. Photoreceptor loss occurred in the injected regions in some of the eyes. By contrast, comparison of dose-response analysis with a dose-response study of light damage strongly suggests that therapeutic doses of CNTF exist that do not suppress ERG responses. CONCLUSIONS: Intraocular delivery of CNTF, which preserves photoreceptors in animal models of retinal degeneration, impairs visual function in normal rats at very high doses, but not at lower doses that still provide protection from constant light damage. 相似文献